Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 82,405 | 88,654 | 47,918 | 58,394 | 69,968 |
| Receivables | 5,459 | 724 | 2,283 | 4,477 | 6,085 |
| Other current assets | 1,145 | 2,268 | 1,801 | 1,926 | 1,726 |
| TOTAL | $89,009 | $91,646 | $52,002 | $64,797 | $77,779 |
| Non-Current Assets | |||||
| PPE Net | 4,909 | 5,371 | 5,878 | 6,404 | 6,093 |
| Investments And Advances | 3,516 | 3,608 | 3,608 | 3,608 | 3,608 |
| Other Non-Current Assets | 200 | 200 | 1,250 | 1,137 | 200 |
| TOTAL | $8,625 | $9,179 | $10,736 | $11,149 | $9,901 |
| Total Assets | $97,634 | $100,825 | $62,738 | $75,946 | $87,680 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,043 | 7,835 | 9,683 | 6,648 | 5,478 |
| Other current liabilities | 115 | 114 | 112 | 107 | 91 |
| TOTAL | $6,362 | $7,949 | $9,795 | $6,755 | $5,569 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 204 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,541 | 1,728 | 1,635 | 1,781 | 1,392 |
| TOTAL | $1,805 | $61,728 | $1,635 | $1,781 | $1,392 |
| Total Liabilities | $8,167 | $69,677 | $11,430 | $8,536 | $6,961 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,708 | 33,542 | 33,362 | 33,039 | 32,809 |
| Common Shares | 44 | 44 | 43 | 43 | 42 |
| Retained earnings | -366,496 | -421,982 | -399,055 | -380,255 | -363,154 |
| Other shareholders' equity | -25 | -33 | -33 | -33 | -33 |
| TOTAL | $89,467 | $31,148 | $51,308 | $67,410 | $80,719 |
| Total Liabilities And Equity | $97,634 | $100,825 | $62,738 | $75,946 | $87,680 |